Manuscripts
Showing 1554 manuscripts.
Cryptococcus neoformans pulmonary infection in HIV-1-infected patients
Citation
Rebecca Adair Clark, Donald Greer, Gregory Thomas Valainis, Newton E. Hyslop. Cryptococcus neoformans pulmonary infection in HIV-1-infected patients. Journal of Acquired Immune Deficiency Syndromes. 1990. 3: 480-4.Year
1990
Journal
Journal of Acquired Immune Deficiency Syndromes
Detection of human immunodeficiency virus type 1 in AIDS patients using amplification-mediated hybridization analyses: reproducibility and quantitative limitations
Citation
Glenn Davis, K. Blumeyer, L.J. DiMichele, K.M. Whitfield, H. Chappelle, N. Riggs, S.S. Ghosh, P.M. Kao, E. Fahy, D.Y. Kwoh, John C. Guatelli, Stephen A. Spector, Douglas D. Richman, Thomas Gingeras. Detection of human immunodeficiency virus type 1 in AIDS patients using amplification-mediated hybridization analyses: reproducibility and quantitative limitations. Journal of Infectious Diseases. 1990. 162: 13-20.Year
1990
Journal
Journal of Infectious Diseases
Pneumocystis carinii pneumonia: advances in diagnosis and therapy
Citation
Neil A. Ettinger. Pneumocystis carinii pneumonia: advances in diagnosis and therapy. Missouri Medicine. 1990. 87: 19-22.Year
1990
Journal
Missouri Medicine
The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner
Citation
Elizabeth A. Holley-Guthrie, Evelyn Byrd Quinlivan, Eng-Chung Mar, Shannon Kenney. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner. Journal of Virology. 1990. 64: 3753-9.Year
1990
Journal
Journal of Virology
The role of interferons in the control of HIV replication in macrophages
Citation
Richard S. Kornbluth, Philip S. Oh, James R. Munis, Patrick H. Cleveland, Douglas D. Richman. The role of interferons in the control of HIV replication in macrophages. Clinical Immunology and Immunopathology (Now Clin Immunol). 1990. 54: 200-19.Year
1990
Journal
Clinical Immunology and Immunopathology (Now Clin Immunol)
Limited sequence heterogeneity among biologically distinct human immunodeficiency virus type 1 isolates from individuals involved in a clustered infectious outbreak
Citation
T. McNearney, P. Westervelt, B. J. Thielan, D. B. Trowbridge, Juan C. Garcia, R. Whittier, Lee Ratner. Limited sequence heterogeneity among biologically distinct human immunodeficiency virus type 1 isolates from individuals involved in a clustered infectious outbreak. Proceedings of the National Academy of Sciences of the United States of America. 1990. 87: 1917-21.Year
1990
Journal
Proceedings of the National Academy of Sciences of the United States of America
Safety and tolerance of dideoxycytidine as a single agent: results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex
Citation
Thomas C. Merigan, Gail Skowron. Safety and tolerance of dideoxycytidine as a single agent: results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. American Journal of Medicine. 1990. 88: 11S-15S.Year
1990
Journal
American Journal of Medicine
Alternating and intermittent regimens of zidovudine (3'-azido-3'-deoxythymidine) and dideoxycytidine (2',3'-dideoxycytidine) in the treatment of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (review)
Citation
Gail Skowron, Thomas C. Merigan. Alternating and intermittent regimens of zidovudine (3'-azido-3'-deoxythymidine) and dideoxycytidine (2',3'-dideoxycytidine) in the treatment of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (review). American Journal of Medicine. 1990. 88: 20S-23S.Year
1990
Journal
American Journal of Medicine
Effect of oral dextran sulfate on the mouse intestinal tract
Citation
C. Wells, Frank S. Rhame. Effect of oral dextran sulfate on the mouse intestinal tract. Journal of Acquired Immune Deficiency Syndromes. 1990. 3: 361-5.Year
1990
Journal
Journal of Acquired Immune Deficiency Syndromes
Considerations in the selection of end points for AIDS clinical trials
Citation
David A. Amato, Stephen W. Lagakos. Considerations in the selection of end points for AIDS clinical trials. Journal of Acquired Immune Deficiency Syndromes. 1990. 3: S64-8.Year
1990
Journal
Journal of Acquired Immune Deficiency Syndromes